Urinary Bladder Neoplasms: all 1,649 studies
Page 15 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.
- The Impact of Early Feeding After Radical Cystectomy for Bladder CancerCompletedNCT01489800Not applicable
- A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
- Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)TerminatedNCT01475266Phase 2/3
- Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder CancerCompletedNCT01458847Phase 1
- A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerCompletedNCT01454089Phase 2
- The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)Status unknownNCT01447199
- Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder TumorsCompletedNCT01446822Not applicable
- Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder CancerCompletedNCT01442519Phase 3
- Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder CancerTerminatedNCT01438112Phase 2/3
- Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder CancerCompletedNCT01395225
- Safety Study of MGA271 in Refractory CancerCompletedNCT01391143Phase 1
- PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial CancerTerminatedNCT01374789Phase 2
- Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)CompletedNCT01373398Phase 1
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
- Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder RadiotherapyCompletedNCT01343121Not applicable
- Multimodal Rehabilitation Program to Bladder Cancer PatientsCompletedNCT01329107Not applicable
- A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)TerminatedNCT01314664
- Hexvix Photodynamic Therapy in Patients With Bladder CancerCompletedNCT01303991Phase 1
- First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBCWithdrawnNCT01284205Phase 3
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Perioperative Outcome in Patients Undergoing Radical CystectomyCompletedNCT01276665Not applicable
- Neobladder Posterior Wall Suspended With Round Ligament of UterusCompletedNCT01273987Not applicable
- Pazopanib and Vinflunine in Urothelial Cancer of the BladderCompletedNCT01265940Phase 1/2
- Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)CompletedNCT01264744
- Clinical Study of Microdosing Carboplatin in Lung or Bladder CancerTerminatedNCT01261299Early Phase 1
- A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before CystectomyTerminatedNCT01245660Early Phase 1
- Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder CancerCompletedNCT01240824Early Phase 1
- Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderStatus unknownNCT01222676Phase 2
- Sorafenib in Urothelium Cancer of BladderTerminatedNCT01215266Phase 2
- Eingeschränkte vs Ausgedehnte Lymphadenektomie LEACompletedNCT01215071Not applicable
- Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic MarkerStatus unknownNCT01198808
- Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder CancerStatus unknownNCT01196403Phase 2
- Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerCompletedNCT01191892Phase 2
- Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal CancerCompletedNCT01170299Not applicable
- 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder CancerCompletedNCT01162785Phase 1
- Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder CancerCompletedNCT01149174Phase 3
- Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder CancerCompletedNCT01142102Not applicable
- B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
- 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the BladderStatus unknownNCT01124682Phase 1
- Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerStatus unknownNCT01118039Phase 2
- Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine ChemotherapyCompletedNCT01104350Phase 1
- Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder CancerStatus unknownNCT01094964Phase 3
- A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)TerminatedNCT01094496Phase 2
- Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT01090466Phase 1/2
- Bladder Cancer Patient-Reported OutcomesCompletedNCT01090388
- Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)CompletedNCT01089088Phase 2
- Incontinent Urinary Diversion Using an Autologous Neo-Urinary ConduitCompletedNCT01087697Phase 1
- Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerStatus unknownNCT01087268Phase 3
- Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)Status unknownNCT01082510Phase 3
- Randomized Trial Comparing Robotic and Open Radical CystectomyCompletedNCT01076387Phase 3
- Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to TreatmentCompletedNCT01031875Phase 2
- Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal CancerCompletedNCT01016639Phase 1/2
- Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871CompletedNCT01015963
- A Comparison of the Studer Pouch Versus the T-Pouch Orthotopic Neobladder Urinary Diversion in Bladder Cancer PatientsCompletedNCT01008865Not applicable
- Markers of Response to Intravesical Bladder Cancer TherapyCompletedNCT01007058
- A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesCompletedNCT01004224Phase 1
- Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band ImagingCompletedNCT01004211Not applicable
- Adaptive Planning in Bladder CancerStatus unknownNCT01000129Phase 2
- Image-Guided Tumorboost of Bladder CancerCompletedNCT00963404Phase 1/2
- Biomarker Discovery and Application in Bladder CancerStatus unknownNCT00962052
- A Study for Treatment of Superficial Bladder Cancer Using OGX-427Status unknownNCT00959868Phase 1
- A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the UrotheliumStatus unknownNCT00949455Phase 2/3
- 3 Tesla MRI in Patients With Bladder CancerActive, not recruitingNCT00938145Not applicable
- Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial CarcinomaTerminatedNCT00933374Phase 2
- A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder CancerTerminatedNCT00918008
- Cone Beam Computed Tomography (CT) BladderCompletedNCT00913536Not applicable
- Observational Study of Subjects Having Routine Recurrence Screening for Bladder CancerCompletedNCT00903240
- A Genotype-Phenotype Urothelial Cancer RegistryActive, not recruitingNCT00902590
- Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsCompletedNCT00900276
- Safety Study on AdCD40L Gene Therapy for Bladder CancerCompletedNCT00891748Phase 1/2
- Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder CancerWithdrawnNCT00880854Phase 1
- Molecular Analysis Of Bladder CancerActive, not recruitingNCT00871754
- Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder CancerCompletedNCT00867347Phase 3
- Screening for Bladder CancerCompletedNCT00848627
- Genetic Susceptibility to Bladder CancerActive, not recruitingNCT00848289
- The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced DiseaseCompletedNCT00829920
- Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
- Activity Study of Sunitinib In Metastatic Pretreated Urothelial CancerStatus unknownNCT00818350Phase 1/2
- Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral ResectionStatus unknownNCT00816075Phase 2/3
- Fiber-Optic Confocal Microscopy of the Urinary Tract HistopathologyCompletedNCT00801762
- Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerCompletedNCT00792025Phase 2
- Recurrence of Bladder Cancer After Transurethral Resection With HexvixWithdrawnNCT00785694Phase 4
- Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder CancerCompletedNCT00782587Phase 1
- Follow-Up of Bladder Cancer Patients From the New England Study of Environment and HealthCompletedNCT00776178
- Quality of Life and Symptom Management in Patients With Bladder CancerCompletedNCT00772018
- Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00757614
- Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the UrotheliumActive, not recruitingNCT00756639Phase 2
- Quality of Life in Patients With Bladder CancerActive, not recruitingNCT00745355
- Health-Related Quality of Life in Patients With Bladder CancerCompletedNCT00744744
- Selenium in Preventing Cancer Recurrence in Patients With Bladder CancerCompletedNCT00729287Phase 3
- A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)CompletedNCT00709462Phase 1
- Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder CancerCompletedNCT00696579Phase 1/2
- Use of Multiphoton Microscopy in the Diagnosis of CancerCompletedNCT00652210Phase 1
- Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian CancerCompletedNCT00648102Phase 1
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
- Novel Peptide Vaccination for Patients With Advanced Bladder CancerCompletedNCT00635336Phase 1
- Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder CancerStatus unknownNCT00633204Phase 2
- Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder CancerCompletedNCT00627432Phase 2
- Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder CancerCompletedNCT00625664Phase 3
- Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerCompletedNCT00623064Phase 1